SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mi Ra Rho, Dietary Intervention Strategies to Reduce Energy Intake in Diabetes, The Journal of Korean Diabetes, 2015, 16, 1, 43

    CrossRef

  2. 2
    Mi Kyeong Hong, Young Yun Cho, Mi Yong Rha, Jae Hyeon Kim, Moon-Kyu Lee, Six-month Outcomes of Mobile Phone Application-based Self-management in a Patient with Type 2 Diabetes, Clinical Nutrition Research, 2015, 4, 3, 201

    CrossRef

  3. 3
    Luc Van Gaal, Elisabeth Souhami, Tianyue Zhou, Ronnie Aronson, Efficacy and safety of the glucagon-like peptide-1 receptor agonist lixisenatide versus the dipeptidyl peptidase-4 inhibitor sitagliptin in young (<50 years) obese patients with type 2 diabetes mellitus, Journal of Clinical & Translational Endocrinology, 2014, 1, 2, 31

    CrossRef

  4. 4
    Tatiana Dilla, Amparo Valladares, Claudia Nicolay, Javier Salvador, Jesús Reviriego, María Costi, Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain, Applied Health Economics and Health Policy, 2012, 10, 6, 417

    CrossRef

  5. 5
    Tatiana Dilla, Amparo Valladares, Claudia Nicolay, Javier Salvador, Jesús Reviriego, María Costi, Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain, Applied Health Economics and Health Policy, 2012, 10, 6, 417

    CrossRef

  6. 6
    Peter A. Hall, Geoffrey T. Fong, Alice Y. Cheng, Time perspective and weight management behaviors in newly diagnosed Type 2 diabetes: a mediational analysis, Journal of Behavioral Medicine, 2012, 35, 6, 569

    CrossRef

  7. 7
    N. M. McKeown, A. Hruby, E. Saltzman, S. Furlong Choumenkovitch, P. F. Jacques, Weighing in on Whole Grains: A Review of Evidence Linking Whole Grains to Body Weight, Cereal Foods World, 2012, 57, 1, 20

    CrossRef

  8. 8
    R. Tirado, A. Caixàs, Comparativa entre los diversos tratamientos de la hiperglucemia: estrategias para minimizar la ganancia ponderal en la diabetes tipo 2, Avances en Diabetología, 2010, 26, 3, 156

    CrossRef

  9. 9
    J. B. Albu, L. K. Heilbronn, D. E. Kelley, S. R. Smith, K. Azuma, E. S. Berk, F. X. Pi-Sunyer, E. Ravussin, Metabolic Changes Following a 1-Year Diet and Exercise Intervention in Patients With Type 2 Diabetes, Diabetes, 2010, 59, 3, 627

    CrossRef

  10. 10
    Elizabeth K. Hussey, Robert L. Dobbins, Randall R. Stoltz, Nancy L. Stockman, Robin L. O'Connor-Semmes, Anita Kapur, Sharon C. Murray, Debbi Layko, Derek J. R. Nunez, Multiple-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double-Blind Study, The Journal of Clinical Pharmacology, 2010, 50, 6
  11. 11
    Thomas Blevins, Therapeutic Options that Provide Glycemic Control and Weight Loss for Patients with Type 2 Diabetes, Postgraduate Medicine, 2010, 122, 1, 172

    CrossRef

  12. 12
    Peter Kopelman, H. Gerrit Groot, Aila Rissanen, Stephan Rossner, Soren Toubro, Richard Palmer, Rob Hallam, Andrew Bryson, Roger I. Hickling, Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo-controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical), Obesity, 2010, 18, 1
  13. 13
    Amulya T. Siram, Robert Yanagisawa, Maria Skamagas, Weight Management in Type 2 Diabetes Mellitus, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010, 77, 5
  14. 14
    T. Dilla, M. Costi, K.S. Boye, J. Reviriego, N. Yurgin, X. Badia, N. Lara-Suriñach, El impacto de la obesidad en el manejo y evolución de la diabetes mellitus, Revista Clínica Española, 2008, 208, 9, 437

    CrossRef

  15. 15
    E. Bonora, Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight, International Journal of Clinical Practice, 2007, 61,
  16. 16
    J. T. George, H. Dilworth, D. M. Matthews, E. A. McIntyre, G. A. McKay, Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients, Diabetic Medicine, 2007, 24, 1
  17. 17
    Denise Joffe, Robert T. Yanagisawa, Metabolic Syndrome and Type 2 Diabetes: Can We Stop the Weight Gain with Diabetes?, Medical Clinics of North America, 2007, 91, 6, 1107

    CrossRef

  18. 18
    The Influence of Age on the Effects of Lifestyle Modification and Metformin in Prevention of Diabetes, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2006, 61, 10, 1075

    CrossRef

  19. 19
    Alfredo Halpern, Marcio C Mancini, Diabesity, Treatments in Endocrinology, 2005, 4, 2, 65

    CrossRef

  20. 20
    Jaime Arroyo, Xavier Badía, Hermenegildo de la Calle, Javier Díez, Enric Estmatjes, Isabel Fernández, Claudia Filozof, Josep Franch, Gemma Gambús, Ramón Gomis, Javier Navarro, Pedro de Pablos, Tratamiento de los pacientes con diabetes mellitus tipo 2 en atención primaria en España, Medicina Clínica, 2005, 125, 5, 166

    CrossRef

  21. 21
    H. Eyre, R. Kahn, R. M. Robertson, Preventing Cancer, Cardiovascular Disease, and Diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association, Diabetes Care, 2004, 27, 7, 1812

    CrossRef

  22. 22
    Bret H Goodpaster, Donna Wolf, Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes, Pediatric Diabetes, 2004, 5, 4
  23. 23
    S. Klein, N. F. Sheard, X. Pi-Sunyer, A. Daly, J. Wylie-Rosett, K. Kulkarni, N. G. Clark, Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition, Diabetes Care, 2004, 27, 8, 2067

    CrossRef

  24. 24
    Andre J Scheen, Current Management Strategies for Coexisting Diabetes Mellitus and Obesity, Drugs, 2003, 63, 12, 1165

    CrossRef

  25. 25
    P. Dhindsa, A. R. Scott, R. Donnelly, Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year, Diabetic Medicine, 2003, 20, 4
  26. 26
    JoAnn Manson, Patrick Skerrett, Walter Willett, Handbook of Obesity, 2003,

    CrossRef

  27. 27
    Louis J. Aronne, Karen R. Segal, Adiposity and Fat Distribution Outcome Measures: Assessment and Clinical Implications, Obesity Research, 2002, 10, S11
  28. 28
    T. P. Ciaraldi, A. P.S. Kong, N. V. Chu, D. D. Kim, S. Baxi, M. Loviscach, R. Plodkowski, R. Reitz, M. Caulfield, S. Mudaliar, R. R. Henry, Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects, Diabetes, 2002, 51, 1, 30

    CrossRef

  29. 29
    M. Hanefeld, G. Sachse, The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial, Diabetes, Obesity and Metabolism, 2002, 4, 6
  30. 30
    Alison J. Evans, Andrew J. Krentz, Insulin resistance and β-cell dysfunction as therapeutic targets in type 2 diabetes, Diabetes, Obesity and Metabolism, 2001, 3, 4
  31. 31
    Current Awareness, Diabetes/Metabolism Research and Reviews, 2000, 16, 6
  32. 32
    Lucie Nield, Helen Moore, Lee Hooper, Kennedy Cruickshank, Avni Vyas, Vicki Whittaker, Carolyn D Summerbell, Dietary advice for treatment of type 2 diabetes mellitus in adults, The Cochrane Library,
  33. 33
    Clifford J. Bailey, New Drugs for the Treatment of Diabetes Mellitus, International Textbook of Diabetes Mellitus,